CURLF stock sentiment todayCuraleaf Holdings, Inc.
Sentiment verdict
Gossip first, financials second — NEUTRAL at 65% confidence.
Last updated · cached analysis, refreshes periodically
CURLF
Curaleaf Holdings, Inc.A dominant multi-state operator with massive scale, currently hindered by debt loads and the slow pace of U.S. federal legislative reform.
Pick a name and you can add your own 1-, 3- and 6-month price calls — no account needed. The needle above shows where the crowd sits. Calls lock 48 hours after you make them, so every scorecard stays honest.
You'll show up on boards and The Floor under this name. Add an email later to keep your history.
No account needed. You can add an email later to keep your calls.
Already have an account? Sign in
See exactly how analyst targets, gossip sentiment and momentum are weighted into this 6-month forecast.
Sign in to go Pro →Full model breakdown (analyst / gossip / momentum weights) is a Pro feature. Modelled for CURLF. Not financial advice.
Price · last 12 months
Gossip
The narrative is centered on the 'waiting game' for DEA rescheduling (Schedule III) and SAFER Banking legislation. While Curaleaf is praised for its international expansion (Germany), investors are frustrated by price compression in mature U.S. markets and the delay in uplisting to major exchanges.
- ·DEA rescheduling rumors
- ·German recreational market progress
- ·Potential Florida adult-use legalization
- ·TSX listing prestige vs. OTC liquidity
Financial
Curaleaf generates significant revenue but continues to struggle with net losses and high interest expenses. While gross margins remain relatively stable, the tax burden under 280E remains a massive cash flow drag.
- ·Revenue: ~$1.35B (Trailing Twelve Months)
- ·EBITDA Margin: ~23%
- ·High Debt-to-Equity relative to pure-play peers
- ·Negative Net Income due to 280E tax impact
Conviction
Whose money is actually in the stock — insider open-market trades and the patience of the institutional holder base.
Mixed conviction — no decisive signal from insiders or the holder base.
- ·No open-market insider trades in the last 120 days.
Pro shows every named insider trade in the window (buyer, title, size, price, and whether it was a pre-scheduled 10b5-1 sale) plus the full holder register split into patient capital and fast money.
Unlock with Pro →Source: SEC EDGAR Form 4. Option exercises, grants, gifts and tax withholding are excluded — only open-market purchases and sales count. Not financial advice.
Risks
- ·Regulatory deadlock in the U.S. Senate
- ·Price compression in saturated markets like Illinois and Massachusetts
- ·High cost of capital and debt refinancing risks
- ·Legal and compliance risks inherent to OTC trading
Peer temperature
How direct competitors stack up against CURLF right now.
- HOTGTBIFGreen Thumb Industries
HOTTER — maintains superior capital allocation and consistent GAAP profitability compared to Curaleaf's recurring losses.
See full analysis → - HOTTCNNFTrulieve Cannabis
HOTTER — trading at a more attractive EV/EBITDA multiple with a massive catalyst in the upcoming Florida legalization vote.
See full analysis → - NEUTRALVRNOFVerano Holdings
NEUTRAL — offers similar scale but faces similar margin pressures and high-tax headwinds without Curaleaf's international upside.
See full analysis →
- CURLF+4.0%
- GTBIF-4.3%
- TCNNF—
- VRNOF—
AI-generated analysis for informational purposes only. Not financial advice.